Qin Xingsong, Yang Muwen, Zheng Xinyu
Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, China.
Ann Surg Treat Res. 2019 Jul;97(1):1-6. doi: 10.4174/astr.2019.97.1.1. Epub 2019 Jun 26.
The combination of indocyanine green and methylene blue (ICG + MB) was reported to be an efficient tracer method in sentinel lymph node biopsy (SLNB). However, whether this method is superior to MB only or carbon nanoparticles (CN) is controversial. This study was to evaluate the efficacy of the three methods in SLNB for breast cancer, and to analyze its influencing factors.
One hundred eighty patients with early breast cancer were recruited and randomly divided into 3 groups. Each group comprising of 60 patients with SLNB using ICG + MB, MB, and CN, respectively. Then the 3 groups were compared in detection rate, mean number of SLNs, and the detection rates and number of metastatic sentinel lymph nodes (SLNs).
The detection rate of SLNs was 100% (60 of 60) in ICG + MB group, 96.7% (58 of 60), and 98.3% (59 of 60) in MB and CN group, respectively, with no significant difference (P = 0.362). Totally, 204 SLNs (mean ± standard deviation [SD] [range], 3.4 ± 1.4 [2-8]) were detected in ICG + MB group, 102 (1.7 ± 0.7 [0-3]) and 145 (2.4 ± 0.7 [0-6]) in MB and CN group, indicating significant difference (P < 0.001). The detection rate of metastatic SLN was 23.3% (14 of 60) in ICG + MB group, which was higher than 18.3% (11 of 60) and 20% (11 of 60) in MB and CN group, respectively, but showed no statistical significance (P = 0.788).
ICG + MB method was superior to MB only and CN only methods in the mean number of SLNs, thus predicting axillary lymph node metastasis more accurately. Therefore, in areas where the standard method is not available, ICG + MB may be more suitable as an alternative tracer for SLNB.
据报道,吲哚菁绿与亚甲蓝联合使用(ICG + MB)是前哨淋巴结活检(SLNB)中一种有效的示踪方法。然而,该方法是否优于单独使用亚甲蓝或碳纳米颗粒(CN)仍存在争议。本研究旨在评估这三种方法在乳腺癌SLNB中的疗效,并分析其影响因素。
招募180例早期乳腺癌患者,随机分为3组。每组分别有60例患者,分别采用ICG + MB、MB和CN进行SLNB。然后比较3组在前哨淋巴结检出率、前哨淋巴结平均数量以及前哨淋巴结转移的检出率和数量。
ICG + MB组前哨淋巴结检出率为100%(60例中的60例),MB组和CN组分别为96.7%(60例中的58例)和98.3%(60例中的59例),差异无统计学意义(P = 0.362)。ICG + MB组共检测到204个前哨淋巴结(平均值±标准差[SD][范围],3.4±1.4[2 - 8]),MB组和CN组分别为102个(1.7±0.7[0 - 3])和145个(2.4±0.7[0 - 6]),差异有统计学意义(P < 0.001)。ICG + MB组前哨淋巴结转移的检出率为23.3%(60例中的14例),分别高于MB组的18.3%(60例中的11例)和CN组的20%(60例中的11例),但差异无统计学意义(P = 0.788)。
ICG + MB方法在前哨淋巴结平均数量方面优于单独使用MB和单独使用CN的方法,从而能更准确地预测腋窝淋巴结转移。因此,在无法采用标准方法的地区,ICG + MB可能更适合作为SLNB的替代示踪剂。